InterTabac 2025 Insights|BAT Exhibits Full Portfolio, Highlights VUSE Ultra and Introduces Zero-Nicotine Products

Sep.19.2025
InterTabac 2025 Insights|BAT Exhibits Full Portfolio, Highlights VUSE Ultra and Introduces Zero-Nicotine Products
2Firsts’ on-site reporting at InterTabac 2025 in Dortmund, Germany, found that BAT showcased a range of HTP, e-vapor, and nicotine pouch products, with a focus on zero-nicotine e-vapor and the VUSE Ultra line, and set up an interactive experience area.

2Firsts, September 18, 2025, Dortmund, Germany — InterTabac 2025 is being held from September 18 to 20 in Dortmund. During the exhibition, 2Firsts visited the halls and observed that British American Tobacco (BAT) exhibited multiple products, including the glo heated tobacco (HTP) brand, the VUSE e-vapor brand, and the VELO nicotine pouch brand.

 

InterTabac 2025 Insights|BAT Exhibits Full Portfolio, Highlights VUSE Ultra and Introduces Zero-Nicotine Products
BAR booth | Image source: 2Firsts

 

E-vapor: VUSE Ultra as the Flagship, New Zero-Nicotine Product

 

At this year’s show, BAT’s core push is its new e-vapor product, VUSE Ultra. Large-format advertising was deployed on site, and a dedicated zone was set up for display.(Read More:

 

InterTabac 2025 Insights|BAT Exhibits Full Portfolio, Highlights VUSE Ultra and Introduces Zero-Nicotine Products
The BAT booth prominently displayed the VUSE Ultra | Image source: 2Firsts

 

 

InterTabac 2025 Insights|BAT Exhibits Full Portfolio, Highlights VUSE Ultra and Introduces Zero-Nicotine Products
BAT has opened a dedicated area for VUSE Ultra. | Image source: 2Firsts

 

InterTabac 2025 Insights|BAT Exhibits Full Portfolio, Highlights VUSE Ultra and Introduces Zero-Nicotine Products
VUSE Ultra Open | Image source: 2Firsts

 

Notably, BAT also brought the zero-nicotine product VUSE GO 1000. It features a replaceable-pod design, with two pods included in each kit.

 

InterTabac 2025 Insights|BAT Exhibits Full Portfolio, Highlights VUSE Ultra and Introduces Zero-Nicotine Products
VUSE GO 1000 (Zero Ni) | Image Source: 2Firsts

 

InterTabac 2025 Insights|BAT Exhibits Full Portfolio, Highlights VUSE Ultra and Introduces Zero-Nicotine Products
VUSE GO 1000 (Zero Ni, Left) | Image Source: 2Firsts

 

InterTabac 2025 Insights|BAT Exhibits Full Portfolio, Highlights VUSE Ultra and Introduces Zero-Nicotine Products
VUSE GO 1000 (Zero Ni) | Image Source: 2Firsts

 

Heated Tobacco: Focus on glo HYPER PRO

 

InterTabac 2025 Insights|BAT Exhibits Full Portfolio, Highlights VUSE Ultra and Introduces Zero-Nicotine Products
BAT booth | Image source: 2Firsts

 

InterTabac 2025 Insights|BAT Exhibits Full Portfolio, Highlights VUSE Ultra and Introduces Zero-Nicotine Products
glo HYPER PRO | Image Source: 2Firsts

 

InterTabac 2025 Insights|BAT Exhibits Full Portfolio, Highlights VUSE Ultra and Introduces Zero-Nicotine Products
glo HYPER PRO|Image Source: 2Firsts

 

Nicotine Pouches

 

InterTabac 2025 Insights|BAT Exhibits Full Portfolio, Highlights VUSE Ultra and Introduces Zero-Nicotine Products
BAT Products|Image Source: 2Firsts

 

Interactive Booth Area

 

InterTabac 2025 Insights|BAT Exhibits Full Portfolio, Highlights VUSE Ultra and Introduces Zero-Nicotine Products
BAT Booth|Image Source: 2Firsts

 


For more on-the-ground coverage, visit the2Firsts InterTabac Special Section.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Reuters Tracks Big Tobacco’s Shift Beyond Cigarettes as Nicotine Pouches Vie for the Next Growth Curve
Reuters Tracks Big Tobacco’s Shift Beyond Cigarettes as Nicotine Pouches Vie for the Next Growth Curve
As cigarette markets face long-term pressure, major tobacco companies are increasingly turning to nicotine pouches in search of growth beyond combustible tobacco. Reuters has examined whether nicotine pouches can become the next strategic growth platform for companies including Philip Morris International, British American Tobacco and Japan Tobacco. PMI strengthened its position through the acquisition of Swedish Match and its ZYN brand, while BAT and JTI continue expanding their own nicotine pouch portfolios. The category has gained attention because of its smoke-free, device-free format, but regulation, youth-use concerns and market scale will determine whether it can become a long-term growth engine.
Regulations
Aug.18 by 2Firsts Perspectives
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
The Global State of Tobacco Harm Reduction, a project operated by Knowledge·Action·Change, estimates that about 200 million people worldwide use non-combustible nicotine products including vapes, heated tobacco, nicotine pouches and snus. Its 2026 report says use of these products rose alongside declining smoking rates in 28 countries it analyzed. The data do not establish that all 200 million users have quit smoking, nor do they prove a direct causal relationship. GSTHR also says regulatory restrictions on the products continue to expand in many markets.
Sep.10
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
A study by CDC Foundation researchers found no sustained decline in e-cigarette sales across Alabama, Oklahoma and Louisiana, the first three U.S. states to implement e-cigarette directory laws. Louisiana initially saw a significant sales decline, followed by a rebound and a persistent reduction in product availability. Sales also shifted from nontobacco-flavored disposables toward prefilled cartridges, with Vuse Alto driving much of the increase in menthol cartridges. By April 2025, unlisted products still accounted for more than half of e-cigarette nicotine sales in all three states.
Sep.18
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Holdings said the U.S. Food and Drug Administration notified the company on June 23, 2026, that 30 PACHA vape SKUs with submitted PMTAs had been tentatively identified for inclusion on a planned public-facing FDA webpage. Under enforcement guidance issued by FDA in May, the webpage is intended to identify certain unauthorized products for which the agency generally does not intend to prioritize enforcement of premarket authorization requirements. Charlie’s disclosed the development alongside second-quarter revenue of $3.8 million, up 116% year over year.
Aug.25
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
Ahead of the Formula 1 race in Madrid, 67 Spanish and international public-health, medical and consumer organizations have sent an open letter to F1 President and CEO Stefano Domenicali calling for an end to sponsorships linked to the tobacco and nicotine industry, including nicotine pouches, vaping products and heated tobacco. The letter focuses on Philip Morris International’s ZYN partnership with Ferrari and British American Tobacco’s long-running partnership with McLaren and exposure for VELO. The campaign follows a March letter in which more than 160 organizations worldwide made a similar request to Formula 1.
Sep.10